Furthermore, CLDN18high ICC tumors exhibited downregulated CD8+ TILs activation markers (TNFRSF4, GZMB) and upregulated immune checkpoints (PD-L1, CTLA-4) (Figures 3D, E, all P < 0.05). This evidence concerns the gene CTLA4 and intrahepatic cholangiocarcinoma.